Maternal, Newborn, and Child Health
MNCH Service Delivery Interventions
Maternal, Newborn, and Child Health
MNCH Service Delivery InterventionsAnemia in Pregnancy
Managing anemia for healthier pregnancies
Anemia in pregnancy is a widespread public health issue that significantly affects both maternal and fetal health outcomes. It is defined by a low hemoglobin (Hb) concentration, typically below 11 g/dL in the first and third trimesters and below 10.5 g/dL in the second trimester, according to the World Health Organization (WHO) classification. This reduction in the oxygen-carrying capacity of blood can lead to serious complications, including maternal mortality, preterm birth, low birth weight, and impaired infant development.
Anemia is a chronic, under-recognized, and often under-treated condition, affecting over 2 billion people globally, with the greatest burden on women, fetuses, and young children. The most common cause of anemia is iron deficiency, making iron deficiency anemia (IDA) the leading micronutrient deficiency worldwide. However, other contributing factors include folate and vitamin B12 deficiencies, parasitic infections (such as malaria and hookworm), genetic hemoglobinopathies (e.g., sickle cell disease and thalassemia), and chronic diseases.
Pregnant women with anemia face an increased risk of complications, including weakened immunity, increased susceptibility to infections, postpartum hemorrhage, and poor pregnancy outcomes. The fetal consequences of maternal anemia are equally severe, as neonatal birth weight is strongly influenced by maternal hemoglobin levels. Studies have shown that both Hb levels below 9 g/dL and above 11 g/dL are associated with a 2–3 times higher likelihood of small-for-gestational-age (SGA) neonates, highlighting the need for balanced maternal nutrition and anemia prevention strategies.
Addressing anemia in pregnancy requires early detection, routine screening, dietary interventions, iron and folate supplementation, and prompt management of underlying causes. Strengthening antenatal care (ANC) services to ensure adequate iron and folic acid intake, timely deworming, malaria prevention, and access to essential prenatal care is critical to reducing anemia-related complications and improving pregnancy outcomes.
What Are the Benefits of Preventing Anemia in Pregnancy?
Anemia in Postpartum Women
The World Health Organization (WHO) defines postnatal anemia as a hemoglobin (Hb) level below 10 g/dL. Women who have experienced blood loss exceeding 500 mL, had uncorrected anemia during pregnancy, or exhibited symptoms of postpartum anemia should have their full blood count (FBC) checked within 48 hours after delivery to assess their iron status. For postpartum women who are hemodynamically stable, asymptomatic, or only mildly symptomatic with Hb levels below 10 g/L, oral elemental iron supplementation (100–200 mg daily) should be initiated for at least three months. A repeat FBC and ferritin test should be performed at the end of therapy to confirm that hemoglobin and iron stores are fully replenished. Early detection and timely management of postpartum anemia are essential to support maternal recovery, reduce fatigue, and promote overall well-being during the critical postnatal period.
How to Implement
1. Assess Symptoms and Conduct Clinical Examination
- Take a detailed history to identify symptoms such as:
- Fatigue, hair thinning, pica (craving non-food items like ice or dirt), restless leg syndrome, and pagophagia (excessive ice craving).
- Perform a brief physical examination to check for signs of anemia, including:
- Pallor (pale skin and mucous membranes), koilonychia (spoon-shaped nails), atrophic tongue papillae, glossitis (inflamed tongue), and stomatitis (mouth sores).
- Recognize severe anemia symptoms that may indicate congestive cardiac failure, such as:
- Orthopnea (difficulty breathing while lying down), swelling, elevated jugular venous pressure, and pulmonary crackles.
- Refer immediately if signs of severe anemia or heart failure are present.
2. Screen and Diagnose Anemia
- Conduct routine hemoglobin (Hb) testing for all pregnant women at:
- The first antenatal care (ANC) visit.
- At least once per trimester to monitor changes in Hb levels.
- In ideal settings, perform:
- Full blood count (FBC), blood film, and red cell indices to determine anemia type.
- Identify the cause of anemia through additional tests, including:
- Serum ferritin for iron deficiency.
- Serum folate and vitamin B12 levels.
- Screening for infections (malaria, helminths) and chronic inflammation.
- Classify anemia severity based on Hb levels:
- Mild: 10–10.9 g/dL
- Moderate: 7–9.9 g/dL
- Severe: <7 g/dL (requires urgent intervention).
3. Prevent and Treat Anemia Through Nutrition and Supplementation
- Provide dietary counseling and encourage a balanced diet rich in:
- Iron (red meat, poultry, fish, legumes, fortified cereals, leafy greens).
- Folic acid and vitamin B12 (fortified foods, dairy, eggs).
- Vitamin C (citrus fruits, tomatoes, bell peppers) to enhance iron absorption.
- Advise against excessive consumption of:
- Tea and coffee, as they inhibit iron absorption.
- Implement Iron and Folic Acid Supplementation (IFAS) or Multiple Micronutrient Supplementation (MMS):
- WHO recommends daily supplementation with 30–60 mg of elemental iron and 400 mcg of folic acid.
- For pregnant women diagnosed with anemia, prescribe 120 mg elemental iron daily until Hb normalizes.
- Once Hb is in the normal range, continue supplementation for three months and at least until six weeks postpartum to replenish iron stores.
- Educate women on supplementation adherence and how to minimize side effects (e.g., constipation, nausea) by taking iron with food or at bedtime.
4. Manage Underlying Conditions Contributing to Anemia
- Treat infections (e.g., malaria, helminths) following national guidelines.
- Address folate and vitamin B12 deficiencies with appropriate supplementation.
5. Manage Severe Anemia
- Refer women with severe anemia for further evaluation and treatment, which may include:
- Blood transfusion or parenteral iron therapy, depending on clinical severity.
- Administer parenteral iron (from the 2nd trimester onwards) in cases of:
- Confirmed iron deficiency not responding to or intolerant of oral iron therapy.
- Iron III carboxymaltose (Ferrinject) IV, given as a single 1000 mg dose over 15 minutes (maximum 15 mg/kg by injection or 20 mg/kg by infusion).
- Determine blood transfusion needs based on:
- Hb levels, hemorrhage risk, cardiovascular status, and availability of alternative iron therapies.
6. Engage the Community to Raise Awareness
- Conduct community outreach programs to educate pregnant women and families on the signs and risks of anemia.
- Train community health workers to provide education, counseling, and follow-up on anemia prevention and treatment.
- Address cultural beliefs and practices that may contribute to anemia (e.g., dietary restrictions).
Key Indicators
- Incidence of postpartum hemorrhage (PPH) in women diagnosed with anemia
- Coverage of MMS and iron-folic acid supplementation during pregnancy.
- Rates of anemia detection and treatment during pregnancy.
- Proportion of pregnant women screened for anemia during ANC visits.
- Prevalence of anemia among pregnant women.
- Percentage of pregnant women receiving iron-folic acid supplementation.
- Incidence of preterm birth and low birth weight in anemic versus non-anemic mothers.
- Availability of iron supplements in health facilities.
Test Your Knowledge
Earn a Certificate
Tips
- Community Engagement: Educate pregnant women, families, and community health workers on the importance of good nutrition, prevention and treatment of parasitic infections, and iron supplementation.
- Training Healthcare Providers: Enhance the knowledge and skills of healthcare workers on early detection and management of anemia.
- Use Visual Aids and Demonstrations: Enhance understanding through standard operating procedures, clinical decision aids and charts, posters, and practical demonstrations in health facilities and community sessions.
- Supply Chain Management: Ensure a consistent supply of iron-folic acid/ multiple multinutrient supplementation tablets, laboratory reagents and equipment, and other essential commodities and supplies.
- Data Monitoring and Evaluation: Track anemia prevalence, intervention uptake, and compliance to refine strategies and redesign programs.
Challenges
- Poor adherence to supplementation: Use behavior change communication strategies and provide alternative iron formulations for those experiencing side effects.
- Limited access to essential supplements: Strengthen supply chain systems and engage policymakers for sustainable funding.
- Cultural and dietary barriers: Conduct community-based nutrition education and advocate for fortified foods.
- Inadequate screening and diagnosis: Implement point-of-care Hb testing and integrate routine screening into all ANC visits.
Key Resources
- Recommendations on antenatal care for a positive pregnancy experience. WHO 2016
- Antenatal care recommendations for a positive pregnancy experience Nutritional interventions update: Multiple micronutrient supplements during pregnancy WHO 2020
- Diagnosis and treatment of iron deficiency anemia during pregnancy and the postpartum period. Turkish Journal of Obstetrics and Gynecology 2015
- Iron, folic acid, and multiple micronutrient supplementation strategies during pregnancy and adverse birth outcomes in Botswana. The Lancet 2022
- Management of iron deficiency anemia in pregnancy in India. IJHBT 2018
- UK guidelines on the management of iron deficiency in pregnancy. British Society for Haematology 2012
